Evidence map›Paper›PMID 39770532›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Repurposing Dapagliflozin for Mitigation of the Kidney Injury Triggered by Cadmium in Rats: Role of Autophagy, Apoptosis, and the SIRT1/Nrf2/HO-1 Pathway.

Hany H Arab, Musaad M Althobaiti, Abdulaziz S Alharthi, Emad O Almalki, Saif S Alsoubie, Jawad M Qattan, Saeed A Almalki, Ahmed M Ashour, Ahmed H Eid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Gastrodin as a nephroprotective agent: Molecular docking-based modulation of oxidative stress, fibrosis, and inflammation.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hany H ArabDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-4195-6901
Musaad M AlthobaitiDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Abdulaziz S AlharthiCollege of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Emad O AlmalkiCollege of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Saif S AlsoubieCollege of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Jawad M QattanCollege of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Saeed A AlmalkiCollege of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Ahmed M AshourDepartment of Pharmacology and Toxicology, College of Pharmacy, Umm Al Qura University, P.O. Box 13578, Makkah 21955, Saudi Arabia.ORCID 0000-0002-2118-0499
Ahmed H EidDepartment of Pharmacology, Egyptian Drug Authority (EDA)-Formerly NODCAR, Giza 12654, Egypt.

Funding

Taif University TU-DSPP-2024-116
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMPKautophagycadmiumdapagliflozinnephrotoxicitySIRT1

Identifiers

PMID39770532
PMCPMC11678783

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.